Moderna Inc
(LTS:0A45)
$
39.3575
-1.0175 (-2.51%)
Market Cap: 15.50 Bil
Enterprise Value: 9.98 Bil
PE Ratio: 0
PB Ratio: 1.30
GF Score: 58/100 Moderna Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Oct 03, 2019 / 02:05PM GMT
Eliana Rachel Merle
Cantor Fitzgerald & Co., Research Division - Research Analyst
Good morning, everyone. Thank you, very much for joining us today. I'm Ellie Merle, I'm one of the biotech analysts here at Cantor. We are very happy to have Moderna here with us today. Thank you very much for attending.
Lorence H. Kim
Moderna, Inc. - CFO
Thank you for having us.
Eliana Rachel Merle
Cantor Fitzgerald & Co., Research Division - Research Analyst
With us from Moderna is Lorence Kim, the CFO. So thank you very much for joining us.
Questions & Answers
Eliana Rachel Merle
Cantor Fitzgerald & Co., Research Division - Research Analyst
And I guess, just to kick it off, you guys have made a lot of progress in the past couple of years and you have a lot of programs in development. Can you sort of frame for us, when you think about your platform kind of some of the technological challenges and the ones that with the positive vaccine data, you feel like you
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot